What is Obinutuzumab?

Category: Prescription Drugs

Most popular types: Gazyva


Obinutuzumab in combination with chlorambucil, is used for the treatment of patients with previously untreated chronic lymphocytic leukemia (CLL).

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 1
Mild 2
None 1

Commonly reported side effects and conditions associated with Obinutuzumab

Side effect Patients
Fatigue 1
Nausea 1


Based on patients currently taking Obinutuzumab

Dosage Patients
25 mg every 3 months 1
25 mg monthly 1

Why patients stopped taking Obinutuzumab

Multiple reasons could be selected

Reason Patients
Course of treatment ended 1
See 1 patient who's stopped taking Obinutuzumab


Currently taking Obinutuzumab

Duration Patients
1 - 6 months 1
1 - 2 years 1

Stopped taking Obinutuzumab

Duration Patients
1 - 6 months 1
Adherence Evaluations
Always 3
Usually 1
Sometimes 0
Never taken as prescribed 0
Burden Evaluations
Very hard to take 0
Somewhat hard to take 2
A little hard to take 1
Not at all hard to take 1
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 3
Not specified 1

What people switch to and from

Patients started taking Obinutuzumab after stopping:

Treatment Patients
Rituximab (Rituxan) 2
Last updated:

1 patient evaluation for Obinutuzumab

Aug 26, 2017 (Started Feb 28, 2017)

  • Effectiveness
    Can't tell (for follicular lymphoma)
  • Side effects
    Moderate (nausea)
  • Adherence
  • Burden
    Somewhat hard to take
Dosage: 25 mg Every 3 months
Advice & Tips: Currently on hold with this treatment. Side effects of Bendeka/Gazyva have been so severe I had to srop both. I have had one treatment with Gazyva alone with inconclusive results. If and when I recover from the Bendeka side effects, I will likely try Gazyva again.

  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for Obinutuzumab